Physician profile
Dev Patel
NPI 1972966836
$7,731.90
in general payments reported to CMS, 2019-2025
19 companies · $35.48 in 2025
The $35.48 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $241 · 2021: $629 · 2022: $4,260 · 2023: $1,943 · 2024: $415 · 2025: $35.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993 · Travel and Lodging: $275 · Grant: $125 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,993.21 |
| Travel and Lodging | $275.23 |
| Grant | $125.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,112.04 | 2019-2025 | Filterwire Ez, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Edwards Lifesciences Corporation | $1,231.64 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $688.44 | 2022-2023 | Mitraclip, Coroflow, Optis |
| Shockwave Medical, INC | $303.54 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $277.82 | 2019-2021 | |
| Cardiovascular Systems INC. | $268.20 | 2022 | |
| Medtronic, INC. | $197.73 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $148.27 | 2021 | |
| Chiesi USA, INC. | $123.64 | 2021-2022 | |
| Inari Medical, INC. | $100.75 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $89.90 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $39.25 | 2022 | |
| Alexion Pharmaceuticals, INC. | $30.59 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $25.88 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.93 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.63 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.95 | 2019 | |
| Lantheus Medical Imaging, INC. | $16.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.57 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dev Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.